Xie Liangzhi, Member of the National Committee of the Chinese People’s Political Consultative Conference and Chairman of China Cell: The Comprehensive Registration System Is Gradually Approaching and Further Optimizing Financing Channels_Oriental Fortune Network

Xie Liangzhi, member of the National Committee of the Chinese People’s Political Consultative Conference and chairman of China CellsecuritiesThe reporter of the newspaper said in an interview that the full implementation of the stock issuance registration system will play a very important role in promoting and promoting my country’s scientific and technological innovation and the real economy, and to a certain extent, solve the financing problems of scientific and technological innovation enterprises.

He suggested to further optimize the financing channels and policies for innovative companies on the Sci-Tech Innovation Board, formulate and optimize the refinancing policies for listed companies in a targeted manner according to the special needs of unprofitable innovative R&D companies, speed up the approval and registration process, and reduce unnecessary restrictions. At the same time, expand the financing channels of enterprises and allow large-scale enterprisesshareholderof listed companiespledgefor supporting business developmentBankloan.

“Landing in the capital market is of great significance to the high-quality development of enterprises.” Xie Liangzhi said that by raising funds through the listing on the Science and Technology Innovation Board, China Cell successfully launched the first domestically-produced cell phone in 2021.reorganizationThe eight-factor product has effectively alleviated the problem of insufficient drug use in patients with the rare disease hemophilia A; at the same time, it has also accelerated the clinical research and industrialization process of the 14-valent HPV vaccine for China Cell, and promoted the clinical II/III of multiple tumor treatment products. Period studies have provided significant financial support. November 2021, company orientationAdditional issuanceThe approval of the project also shows the affirmation and recognition of the company by the capital market. “With the support of the Science and Technology Innovation Board, we have the confidence and ability to develop more and better products, solve the accessibility of more high-end drugs, and contribute to the cause of people’s health.”

(Article source: ChinasecuritiesReport · China Securities Network)

Article source: China Securities Journal China Securities Network

Responsible editor: 3

Original title: Member of the National Committee of the Chinese People’s Political Consultative Conference and Chairman of China Cell Xie Liangzhi: The comprehensive registration system is gradually approaching, and the financing channels are further optimized